A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

Completed

Plain-English translation of NCT03104413 on ClinicalTrials.gov ↗ · Source last updated June 2022 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(403 sites)

United States

Phoenix VA Health Care System /ID# 162261, Phoenix, Arizona

HonorHealth Research Institute - Shea /ID# 165825, Scottsdale, Arizona

Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211882, Tempe, Arizona

University of Arizona /ID# 158305, Tucson, Arizona

Duplicate_Atria Clinical Research /ID# 164504, Little Rock, Arkansas